Johnson&Johnson

U.S. limits use of J&J’s COVID vaccine on blood clot risks

The U.S. health regulator said it was limiting the use of Johnson & Johnson's COVID-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest…

Italy and France approve J&J’s COVID-19 vaccine, also gets WHO emergency listing approval

Italy’s medicines agency AIFA and France’s health regulator, the Haute Autorite de Sante (HAS), said on Friday they have approved the use of the COVID-19 vaccine produced by Johnson &…

World’s largest genetics project to tackle deadly diseases launched in the UK

A new ground-breaking project in the fight against life-threatening illnesses has launched today in the UK. The £200 million whole genome sequencing project is being created, forming a partnership of…